Abstract-The present study describes the potentiating effect of dimorpholamine on twitch contraction of skeletal muscle and its mechanism on a cellular basis. Low concentrations (about 2 x 10-5 g/ml) of dimorpholamine potentiate the twitch con traction of frog sartorius muscle. In relatively high concentrations of 10-4-10-3 g/ml, however, the potentiation was followed by depression. Endplate potential was not affected by the drug. Dimorpholamine depolarized slightly the muscle membrane. The contracture tension vs. membrane potential relationship was hardly affected by the drug in the presence of 2 x 10-1 M tetrodotoxin.
Dimorpholamine (N,N'-dibutyl-N,N'-dicarboxymorpholide-ethylenediamine;
Th1064)
has clinically been used as a potent analeptic since its introduction as a respiratory stimulant (1, 2) . The actions of dimorpholamine are summarized as follows: the drug increases the release of neurotransmitter or pressor amines (3, 4, 5) ; stimulates contractile responses in smooth muscle and cardiac muscle (6, 7); and enhances respiratory activities (1, 2, 8) . The pharmacological actions are characterized by evanescent effects (6, 9) , tachyphylaxis (7) and a dual effect with high doses, potentiation followed by depression (6) . Little is, however, of the detailed mechanism of the actions of dimorpholamine on a cellular basis. We describe herein the potentiating effect of dimorpholamine on twitch contraction of skeletal muscle, in which the mode of action is to prolong the duration of the action potential. The inherent molecular mechanism of this drug may be to suppress activity related to the sodium and potassium gates. A preliminary report has appeared elsewhere (10) .
MATERIALS AND METHODS
Nerve-sartorius muscle preparations of the frog, Rana nigromaculata, were removed with special precautions taken to avoid damage to the pelvic end of the muscles, and were then stored at room temperature (20'C) for about one hour before use.
Mechanical activity: The muscles were horizontally mounted in a bath (10 ml), stretched to 120 % of the resting length in situ. Nerve or muscle was stimulated by means of platinum electrodes with supramaximal (30%) rectangular pulses for 0.2 msec. The isometric tensions were observed on an oscillogram and ink-writing recorder through a mechanotransducer (5734A, Toshiba or a strain gauge). K-contracture was induced by replacing Na with K. With concentrations above 120 mM, KCI was hypertonically added.
Electrophysiology: The muscles were fixed in a chamber (2 ml in the sense of the mechanical threshold (13, 14, 15; also cf. Fig. 9 ).
Prolongation of action potential
Contractile response was decoupled from excitation of the sarcoplasmic membrane by pretreatment with ethylene glycol (11) and the muscle fiber was excited by nerve or whole muscle stimulation. At a concentration of 3 x 10-5 g/ml, dimorpholamine elongated the falling phase of the action potential without affecting the rising phase, and had little effect on peak amplitude (Fig. 6a) . At a relatively higher concentration (3X 10-4 g/ml), the prolongation became more pronounced and the peak amplitude and rate of rise were decreased to a small extent with the membrane potential depolarized by several mV (Fig.   6b, c) . After 7 min, the action potential began to repeat (Fig. 6c) , showing enhancement of muscle membrane excitability. The repetitive spikes disappeared after washout (Fig.   6d ), and the membrane potential also returned to the original level after 30 min.
The action potential became abortive 20 min after dimorpholamine, 3 x 10-4 g/ml, but nerve stimulation still elicited almost the same muscle response as the muscle stimulation (lower traces in Fig. 7 ). This result indicates that synaptic activity was still functional in this preparation even when the excitability of the muscle membrane was lost. Effect on end-plate potential and electrotonic potential Two microelectrodes were inserted into a curarized muscle fiber near the end-plate, one to record the membrane potential, the other, 100-200 am away, to inject current. The end-plate potential and electrotonic potential were both derived from the same point-source of current, which circumvented a complexity of the cable properties in estimation of the effect of change in membrane resistance on the end-plate potential. The experiment is illustrated in Fig. 8 . The results of five experiments are summarized in Table 1 . The slight decrease in end-plate potential was proportionally reflected in the slight change seen in the electrotonic potential (Table 1) and depolarization, 2 mV on the average. These results support the idea that dimorpholamine had no effect on the postsynaptic muscle membrane.
Effect on facilitation of transmitter release
Since dimorpholamine markedly facilitates crayfish neuromuscular transmission (5), the effect on frog neuromuscular transmission was also investigated. A train of three stimuli was added at 100/sec in 12 mM Mg solution. End-plate potential was then subject to facilitation, the degree of which is given by the ratio of the potentials between successive stimuli in Table 2 . In contrast to the crayfish neuromuscular junction, facilitation was not augmented in frog sciatic nerve-sartorius preparation. End-plate potential and electrotonic potentials were alternately produced by stimulating the sciatic nerve or by injecting a constant current of 2 x 10-8 A for 50 msec in a muscle fiber curarized with 2 x 10-6 g/ml d-tubocurarine.
Potentials in column b were recorded 5 min after drug ap plication, 10-' g/ml. 
DISCUSSION
A mechanical threshold and a mechanical saturation in the membrane potential has been suggested (13, 14, 16) . The basic explanation of the role of the action potential in E-C coupling is that the concentration of activator Ca++ in the myoplasm is directly pro portional to the area of the action potential (mV-sec) between the mechanical threshold and the mechanical saturation potential (14, 15) . Based on these empirical theories, it was deemed worthy to estimate the amount of twitch potentiation which could be expected from the prolonged duration of the action potential (Fig. 6 ). For simplicity, the mechanical threshold and the mechanical saturation potential were assumed to be -50 mV and -20 mV respec tively (14) . The amount of twitch potentiation as calculated from the potential shift in Fig. 5 (2 mV at 50% contracture tension if significant) was only 10% (c in Fig. 9 ), whereas the prolongation of the action potential integrated to produce about 600 % increase in the twitch tension (b in Fig. 9 ).
Considering the possible occurrence of a repetitive discharge during the twitch (Fig. 6C) , the expected potentiation of the twitch contraction would be more than 600%. A maxi mum potentiation observed in the whole muscle contraction was, however, 2.5 times the control when 10-3 g/ml of dimorpholamine was used ( Fig. 2A) . As the higher concen tration of the drug suppresses more rapidly the action potential (Fig. 3) , a time lag of the drug action on each muscle fiber (due to the diffusion) may reasonably explain the relatively smaller amount of potentiation observed in the whole muscle experiment than that estimated in Fig. 9 . Dimorpholamine apparently belongs to type B drugs (14) . This is well reconciled with the fact that the onset of tension output and the rate of rise of the tension output, dP/dt, during the foot of the contraction period were not altered (Fig. le) . The most remarkable effect of dimorpholamine on the action potential is to prolong its falling phase with little effect on the rising phase (Fig. 6a, b) . A block of the potassium channel (gK decrease) may to some extent account for the drug effect, but this block alone does not adequately explain the considerable prolongation of the action potential as observed in Fig. 6b , c, thereby suggesting additional involvement of the inactivating gate (h) block in terms of the kinetic model proposed by Adrian et al. (17, also cf. 18) . Since the observed depolarization is inadequate to generate such a repetitive discharge (cf. Fig. 6c) , block of the potassium channel should exist to attain the repetitive discharge in Fig. 6 (18) . The observation in Fig. 6d is of great interest : When the membrane potential was returning to the control resting potential level after washout (Fig. 6d) , a transient decrease in the rate of rise of the action potential was observed. Therefore, the decrease in the rate of rise would not be due to depolarizing inactivation but rather to a direct suppressive effect of the drug on the m gate of the sodium channel. It is likely that dimorpholamine exerts blocking actions on all n, m, and h gates with different time courses and sensitivity. The synaptic transmission was not affected by the drug (Figs. 7, 8 ; Tables 1, 2 ). Therefore, the more pronounced depression observed in twitch contraction by nerve stimulation in Fig. 3 may be due to a nerve membrane which is suppressed by dimorpholamine as is the muscle membrane although such is not the case in the experiments shown in Figs. 7, 8 and Tables 1,   2 . The excitatory actions observed in a variety of tissues (1-9) may be transient phenomena in the course of the blocking action of this drug on the excitable membranes (Fig. 6 ). Thus the pharmacological characteristics of this drug such as evanescent effects, tachyphylaxis, and the dual effect can all be explained in light of the mechanism suggested. Although a more direct experiment is required to establish the molecular mechanism of the drug action, special care should be taken when this drug is clinically used as an analeptic.
